Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence

Journal of Virology

Volumn 79, Issue 22, 2005, Pages 14235-14243

  De Jesus, Nidia ^a   Franco, David ^a   Paul, Aniko ^a   Wimmer, Eckard ^a   Cello, Jeronimo ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC MARKER; GENOME ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PHENOTYPE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RNA TRANSLATION; TEMPERATURE DEPENDENCE; TRANSGENIC MOUSE; VIRUS ATTENUATION; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; BASE SEQUENCE; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; DNA, VIRAL; MICE; MUTATION; POLIOVIRUS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA, VIRAL; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRULENCE;

ANIMALIA; MUS MUSCULUS; POLIOVIRUS;

EID: 27644573817     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.22.14235-14243.2005     Document Type: Article

References (61)

1. Agol, V. I. 2002. Picornavirus genome: an overview, p. 127-148. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, D.C.
2. Agol, V. I., S. G. Drozdov, T. A. Ivannikova, M. S. Kolesnikova, M. B. Korolev, and E. A. Tolskaya. 1989. Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J. Virol. 63:4034-4038.
3. Andino, R., G. E. Rieckhof, and D. Baltimore. 1990. A functional ribonucleoprotein complex forms around the 5′ end of poliovirus RNA. Cell 63:369-380.
4. Bellmunt, A., G. May, R. Zell, P. Pring-Akerblom, W. Verhagen, and A. Heim. 1999. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265:178-184.
5. Biedler, J. L., L. Helson, and B. A. Spengler. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:2643-2652.
6. Brown, B., M. S. Oberste, K. Maher, and M. A. Pallansch. 2003. Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J. Virol. 77:8973-8984.
7. Cello, J., A. V. Paul, and E. Wimmer. 2002. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297:1016-1018.
8. Cuconati, A., A. Molla, and E. Wimmer. 1998. Brefeldin A inhibits cell-free, de novo synthesis of poliovirus. J. Virol. 72:6456-6464.
9. Dorner, A. J., L. F. Dorner, G. R. Larsen, E. Wimmer, and C. W. Anderson. 1982. Identification of the initiation site of poliovirus polyprotein synthesis. J. Virol. 42:1017-1028.
10. Flanegan, J., R. Pettersson, V. Ambros, M. Hewlett, and D. Baltimore. 1977. Covalent linkage of a protein to a defined nucleotide sequence at the 5′-terminus of virion and replicative intermediate RNAs of poliovirus. Proc. Natl. Acad. Sci. USA 74:961-965.
11. Gromeier, M., L. Alexander, and E. Wimmer. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. USA 93:2370-2375.
12. Gromeier, M., B. Bossert, M. Arita, A. Nomoto, and E. Wimmer. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73:958-964.
13. Gromeier, M., and A. Nomoto. 2002. Determinants of poliovirus pathogenesis, p. 367-379. In B. L. Selmer and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, D.C.
14. Guest, S., E. Pilipenko, K. Sharma, K. Chumakov, and R. P. Roos. 2004. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J. Virol. 78:11097-11107.
15. Haller, A. A., S. R. Stewart, and B. L. Semler. 1996. Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J. Virol. 70:1467-1474.
16. Hellen, C. U. T., and E. Wimmer 1995. Enterovirus genetics, p. 25-71 In H. A. Rotbart (ed.), Human enterovirus infections. ASM Press, Washington, D.C.
17. Hughes, P. J., D. M. Evans, P. D. Minor, G. C. Schild, J. W. Almond, and G. Stanway. 1986. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J. Gen. Virol. 67:2093-2102.
18. Hyypia, T., T. Hovi, N. Knowles, and G. Stanway. 1997. Classification of enteroviruses based on molecular and biological properties. J. Gen. Virol. 78:1-11.
19. Ishii, T, K. Shiroki, D. H. Hong, T. Aoki, Y. Ohta, S. Abe, S. Hashizume, and A. Nomoto. 1998. A new internal ribosomal entry site 5′ boundary is required for poliovirus translation initiation in a mouse system. J. Virol. 72:2398-2405.
20. Ishii, T., K. Shiroki, A. Iwai, and A. Nomoto. 1999. Identification of a new element for RNA replication within the internal ribosome entry site of poliovirus RNA. J. Gen. Virol. 80:917-920.
21. Iwasaki, A., R. Welker, S. Mueller, M. Linehan, A. Nomoto, and E. Wimmer. 2002. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J. Infect. Dis. 186:585-592.
22. Jang, S. K., M. V. Davies, R. J. Kaufman, and E. Wimmer. 1989. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vitro. J. Virol. 63:1651-1660.
23. Jang, S. K., H.-G. Kräusslich, M. J. H. Nicklin, G. M. Duke, A. C. Palmenberg, and E. Wimmer. 1988. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:2636-2643.
24. Kitamura, N., B. L. Semler, P. G. Rothberg, G. R. Larsen, C. J. Adler, A. J. Dorner, E. A. Emini, R. Hanecak, J. Lee, S. van der Werf, C. W. Anderson, and E. Wimmer. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291:547-553.
25. Koike, S., C. Taya, T. Kurata, S. Abe, I. Ise, H. Yonekawa, and A. Nomoto. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA 88:951-955.
26. Korotkova, E. A., R. Park, E. A. Cherkasova, G. Y. Lipskaya, K. M. Chumakov, E. V. Feldman, O. M. Kew, and V. I. Agol. 2003. Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J. Virol. 77:12460-12465.
27. La Monica, N., C. Meriam, and V. R. Racaniello. 1986. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J. Virol. 57:515-525.
28. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent poliovirus in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
29. Lee, Y., A. Nomoto, B. Detjen, and E. Wimmer. 1977. The genome-linked protein of picornaviruses. I. A protein covalently linked to poliovirus genome RNA. Proc. Natl. Acad. Sci. USA 74:59-63.
30. Minor, P. 1997. Poliovirus, p. 555-574. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, Philadelphia, Pa.
31. Mirzayan, C. M., and E. Wimmer. 1992. Genetic analysis of an NTP-binding motif in poliovirus polypeptide 2C. Virology 189:547-555.
32. Molla, A., A. V. Paul, and E. Wimmer. 1991. Cell-free, de novo synthesis of poliovirus. Science 254:1647-1651.
33. Mueller, S., E. Wimmer, and J. Cello. 2005. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res. 111:175-193.
34. Oberste, M. S., K. Maher, D. R. Kilpatrick, and M. A. Pallansch. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 73:1941-1948.
35. Oberste, M. S., K. Maher, and M. A. Pallansch. 1998. Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5′ end of the region encoding VP2. Virus Res. 58:35-43.
36. Palmenberg, A., and J. Y. Sgro. 2002. Alignments and comparative profiles of Picornavirus genera, p. 149-155. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, D.C.
37. Parsley, T. B., J. S. Towner, L. B. Blyn, E. Ehrenfeld, and B. L. Semler. 1997. Poly(rC) binding protein 2 forms a ternary complex with the 5′-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 3:1124-1134.
38. Pelletier, J., M. E. Flynn, G. Kaplan, V. R. Racaniello, and N. Sonenberg. 1988. Mutational analysis of upstream AUG codons of poliovirus RNA. J. Virol. 62:4486-4492.
39. Pelletier, J., G. Kaplan, V. R. Racaniello, and N. Sonenberg. 1988. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5′7-noncoding region. Mol. Cell. Biol. 8:1103-1112.
40. Pelletier, J., and N. Sonenberg. 1989. Internal binding of eukaryotic ribosomes on poliovirus RNA: translation in Hela cell extracts. J. Virol. 63: 441-444.
41. Pincus, S. E., D. C. Diamond, E. A. Emini, and E. Wimmer. 1986. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J. Virol. 57:638-646.
42. Pöyry, T., L. Kinnunen, and T. Hovi. 1992. Genetic variation in vivo and proposed functional domains of the 5′ noncoding region of poliovirus RNA. J. Virol. 66:5313-5319.
43. Racaniello, V. R., and D. Baltimore. 1981. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl. Acad. Sci. USA 78:4887-4891.
44. Reed, L. J., and M. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
45. Ren, R., F. Costantini, E. J. Gorgacz, J. J. Lee, and V. R. Racaniello. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353-362.
46. Rezapkin, G. V., K. M. Chumakov, Z. Lu, Y. Ran, E. M. Dragunsky, and I. S. Levenbook. 1994. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 202:370-378.
47. Rezapkin, G. V., L. Fan, D. M. Asher, M. R. Fibi, E. M. Dragunsky, and K. M. Chumakov. 1999. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Virology 258:152-160.
48. Rezapkin, G. V., L. P. Norwood, R. E. Taffs, E. M. Dragunsky, I. S. Levenbook, and K. M. Chumakov. 1995. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211:377-384.
49. Shiroki, K., T. Ishii, T. Aoki, M. Kobashi, S. Ohta, and A. Nomoto. 1995. A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J. Virol. 69:6825-6832.
50. Shiroki, K., T. Ishii, T. Aoki, Y. Ota, W. X. Yang, T. Komatsu, Y. Ami, M. Arita, S. Abe, S. Hashizume, and A. Nomoto. 1997. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J. Virol. 71:1-8.
51. Simoes, E. A. F., and P. Sarnow. 1991. An RNA hairpin at the extreme 5′ end of the poliovirus RNA genome modulates viral translation in human cells. J. Virol. 65:913-921.
52. Stanway, G., P. J. Hughes, R. C. Mountford, P. Reeve, P. D. Minor, G. C. Schild, and J. W. Almond. 1984. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b Proc. Natl. Acad. Sci. USA 81:1539-1543.
53. Supanaranond, K., N. Takeda, and S. Yamazaki. 1992. The complete nucleotide sequence of a variant of coxsackievirus A24, an agent causing acute hemorrhagic conjunctivitis. Virus Genes 6:149-158.
54. Svitkin, Y. V., S. V. Maslova, and V. I. Agol. 1985. The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147:243-252.
55. Svitkin, Y. V., T. Pestova, S. V. Maslova, and V. I. Agol. 1988. Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology 166: 394-404.
56. Trono, D., R. Andino, and D. Baltimore. 1988. An RNA sequence of hundreds of nucleotides at the 5′ end of poliovirus RNA is involved in allowing viral protein synthesis. J. Virol. 62:2291-2299.
57. van der Werf, S., J. Bradley, E. Wimmer, F. W. Studier, and J. J. Dunn. 1986. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 78:2330-2334.
58. Wimmer, E., C. U. T. Hellen, and X. M. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
59. pro of poliovirus is essential for RNA replication. J. Virol. 69:3658-3667.
60. Yogo, Y., and E. Wimmer. 1972. Polyadenylic acid at the 3′-terminus of poliovirus RNA. Proc. Natl. Acad. Sci. USA 69:1877-1882.
61. Zhang, S., and V. R. Racaniello. 1997. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J. Virol. 71:4915-4920.